Repositive

📍 Cambridge, United Kingdom🗓 Founded 2014👥 2 employees💰 Last funded Jan 2017
Information Technology & Services🌐 repositive.io
Website LinkedIn
Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right CRO partners who have first-class expertise and years of experience in running similar studies, to ensure biopharmas receive the best advice for planning and conducting their oncology projects. Download our latest eBook on AI in drug discovery here: https://mailchi.mp/repositive.io/c1tpoe6oke
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
3
Switzerland
1
Investor activity2015–2017 · investors recorded per year
201512016220171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Repositive?
Repositive has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Repositive last raise funding?
The most recent investment in Repositive recorded on gritt.io was in January 2017.
When was Repositive founded?
Repositive was founded in 2014.
What industry is Repositive in?
Repositive operates in Information Technology & Services. Find similar Information Technology & Services investors on gritt.io.
Where is Repositive based?
Repositive is headquartered in Cambridge, United Kingdom.